Theseus Pharmaceuticals, Inc.
THRXDelisted Feb 14, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001745020
Theseus Pharmaceuticals, Inc. was delisted on Feb 14, 2024; its insiders filed their last Form 4 on Feb 14, 2024; 70 institutions reported holding it in 13F filings for Q4 2023, worth $145.8M in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Theseus Pharmaceuticals, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 63
- −5 vs. Q2 2023
- Shares held
- 35.3M
- −4.67M (−11.7%) vs. Q2 2023
- Total value
- $95.5M
- −$277.5M (−74.4%) vs. Q2 2023
- New holders
- 10
- 19 more added
- Sold out
- 15
- 21 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting THRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 70 | $145.8M |
| Q3 2023 | 63 | $95.5M |
| Q2 2023 | 69 | $373.6M |
| Q1 2023 | 72 | $350.6M |
| Q4 2022 | 47 | $164.8M |
| Q3 2022 | 51 | $200.7M |
| Q2 2022 | 51 | $191.6M |
| Q1 2022 | 47 | $402.8M |
| Q4 2021 | 46 | $441.4M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Theseus Pharmaceuticals, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 17,713,600 | $47.6M | 1.10% | +479,932+2.8% | Added |
| Foresite Capital Management V, LLC | 4,108,796 | $11.1M | 17.63% | +523,450+14.6% | Added |
| Frazier Life Sciences Management, L.P. | 2,248,194 | $6.05M | 0.40% | 00.0% | Unchanged |
| Millennium Management LLC | 1,717,862 | $4.62M | 0.00% | +1,588,867+1,231.7% | Added |
| BlackRock Inc. | 1,340,480 | $3.61M | 0.00% | +6,612+0.5% | Added |
| Price T Rowe Associates Inc | 1,216,500 | $3.27M | 0.00% | −39,509−3.1% | Reduced |
| Vanguard Group Inc | 789,120 | $2.12M | 0.00% | +57,695+7.9% | Added |
| Omega Fund Management, LLC | 711,479 | $1.91M | 1.76% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 702,415 | $1.89M | 1.25% | −54,594−7.2% | Reduced |
| Nextech Invest AG | 611,310 | $1.64M | 0.50% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 437,329 | $1.18M | 0.03% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 405,578 | $1.09M | 0.00% | −15,944−3.8% | Reduced |
| Affinity Asset Advisors, LLC | 400,726 | $1.08M | 0.35% | +160,482+66.8% | Added |
| State Street Corp | 368,660 | $991.7K | 0.00% | +1,144+0.3% | Added |
| Nuveen Asset Management, LLC | 81,898 | $779.7K | 0.00% | −580−0.7% | Reduced |
| Acadian Asset Management LLC | 259,470 | $696.0K | 0.00% | +259,470 | New |
| Driehaus Capital Management LLC | 232,693 | $625.9K | 0.01% | 00.0% | Unchanged |
| TD Asset Management Inc | 213,896 | $575.4K | 0.00% | +106,948+100.0% | Added |
| UBS Oconnor LLC | 181,452 | $488.1K | 0.01% | +60,000+49.4% | Added |
| Laurion Capital Management LP | 171,157 | $460.4K | 0.01% | −8,462−4.7% | Reduced |
| Northern Trust Corp | 157,325 | $423.2K | 0.00% | −6,790−4.1% | Reduced |
| Boxer Capital, LLC | 150,000 | $403.5K | 0.02% | −200,000−57.1% | Reduced |
| Ensign Peak Advisors, Inc | 139,196 | $374.4K | 0.00% | −3,402−2.4% | Reduced |
| Denali Advisors LLC | 127,900 | $344.1K | 0.12% | +111,400+675.2% | Added |
| Renaissance Technologies LLC | 126,194 | $339.0K | 0.00% | +84,994+206.3% | Added |
| Manufacturers Life Insurance Company, The | 79,751 | $214.5K | 0.00% | −8,130−9.3% | Reduced |
| Bank of New York Mellon Corp | 59,553 | $160.2K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 56,203 | $151.2K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 46,153 | $124.2K | 0.00% | −32,840−41.6% | Reduced |
| Morgan Stanley | 38,570 | $103.8K | 0.00% | −1,407−3.5% | Reduced |
| Gsa Capital Partners LLP | 36,587 | $98.0K | 0.01% | +36,587 | New |
| Exchange Traded Concepts, LLC | 36,210 | $97.4K | 0.00% | +21,419+144.8% | Added |
| Walleye Capital LLC | 31,998 | $86.1K | 0.00% | +31,998 | New |
| Rhumbline Advisers | 27,958 | $75.2K | 0.00% | +661+2.4% | Added |
| Prelude Capital Management, LLC | 27,073 | $72.8K | 0.01% | +27,073 | New |
| Two Sigma Investments, LP | 22,651 | $60.9K | 0.00% | −29,150−56.3% | Reduced |
| Squarepoint Ops LLC | 19,653 | $52.9K | 0.00% | +19,653 | New |
| Forefront Analytics, LLC | 17,672 | $47.5K | 0.03% | +17,672 | New |
| Bank of America Corp | 17,415 | $46.8K | 0.00% | +13,413+335.2% | Added |
| Alliancebernstein L.P. | 15,620 | $42.0K | 0.00% | −202,858−92.9% | Reduced |
| JPMorgan Chase & Co | 13,141 | $35.3K | 0.00% | −2,572−16.4% | Reduced |
| Two Sigma Advisers, LP | 12,200 | $32.8K | 0.00% | −18,000−59.6% | Reduced |
| Susquehanna International Group, LLP | 11,112 | $29.9K | 0.00% | +11,112 | New |
| UBS Group AG | 10,750 | $28.9K | 0.00% | +6,520+154.1% | Added |
| Principal Financial Group Inc | 10,679 | $28.7K | 0.00% | 00.0% | Unchanged |
| American Century Companies Inc | 10,514 | $28.3K | 0.00% | +10,514 | New |
| American International Group, Inc. | 10,100 | $27.2K | 0.00% | +359+3.7% | Added |
| New York State Common Retirement Fund | 9,606 | $25.8K | 0.00% | +72+0.8% | Added |
| Barclays PLC | 7,832 | $21.1K | 0.00% | −533−6.4% | Reduced |
| Royal Bank of Canada | 6,756 | $18.0K | 0.00% | +4,644+219.9% | Added |
| Tower Research Capital LLC (TRC) | 5,734 | $15.4K | 0.00% | +5,036+721.5% | Added |
| Wells Fargo & Company | 4,981 | $13.4K | 0.00% | −2,728−35.4% | Reduced |
| California State Teachers Retirement System | 4,466 | $12.0K | 0.00% | −2,266−33.7% | Reduced |
| Advisor Group Holdings, Inc. | 2,793 | $7.51K | 0.00% | 00.0% | Unchanged |
| STRS Ohio | 2,700 | $7.00K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 1,930 | $5.19K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,796 | $5.00K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 889 | $2.39K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 870 | $2.34K | 0.00% | −7,104−89.1% | Reduced |
| FMR LLC | 755 | $2.03K | 0.00% | −804,886−99.9% | Reduced |
| Red Tortoise LLC | 536 | $1.44K | 0.00% | +536 | New |
| Glassman Wealth Services | 241 | $648 | 0.00% | +241 | New |
| Citigroup Inc | 15 | $40 | 0.00% | −6,014−99.8% | Reduced |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −1,950,327−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −1,400,352−100.0% | Sold out |
| VR Adviser, LLC | 0 | $0 | 0.00% | −770,000−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −633,423−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −604,550−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −597,500−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −277,074−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −270,015−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −153,673−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −136,719−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −28,941−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −10,330−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −1,126−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −163−100.0% | Sold out |
| Tekla Capital Management LLC | – | – | – | – | Not filed |